MARKET

ABP

ABP

ABPRO HLDGS INC
NASDAQ
1.500
0.000
0.00%
After Hours: 1.462 -0.038 -2.51% 19:18 02/06 EST
OPEN
1.490
PREV CLOSE
1.500
HIGH
1.550
LOW
1.460
VOLUME
23.76K
TURNOVER
--
52 WEEK HIGH
34.65
52 WEEK LOW
1.440
MARKET CAP
4.07M
P/E (TTM)
-0.0616
1D
5D
1M
3M
1Y
5Y
1D
Abpro Holdings Directors Resign, Board Seeks Replacements
TipRanks · 5d ago
Abpro Holdings Directors Anthony Eisenberg and Sooyoung Lee Resign
Reuters · 5d ago
Weekly Report: what happened at ABP last week (0126-0130)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 01/28 17:05
Weekly Report: what happened at ABP last week (0119-0123)?
Weekly Report · 01/26 09:13
Abpro Holdings Secures $147,000 Unsecured Loan from CEO to Fund D&O Insurance
Reuters · 01/26 07:47
Abpro Holdings Secures Insider Loan and Refreshes Board
TipRanks · 01/23 22:23
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 01/21 12:05
More
About ABP
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Webull offers ABPRO Holdings Inc stock information, including NASDAQ: ABP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABP stock methods without spending real money on the virtual paper trading platform.